The Vision

To make disease-modifying first-in-class immuno-oncology treatments available to patients suffering from devastating conditions such as cancer

How do we achieve our vision

Medibiofarma focused internal resources on areas where lies the experience of the management team:

  • Virtual drug design
  • Medicinal Chemistry
  • In Vitro Pharmacology
  • Intellectual Property

The remaining activities needed for the full compound characterization and the nomination of a development candidate, such as in vivo pharmacology and toxicology and IND-enabling studies  are carried out through partnerships with several companies (CROs), Research Centers and Universities.

Last News

This website uses cookies so that you have the best user experience. If you continue browsing you are giving your consent for the acceptance of the mentioned cookies and the acceptance of our Cookies policy.
. ACEPTAR

Aviso de cookies